Table 3 Comparison of the studied variables according to age (≤64 and ≥ 65 years)
From: Non Hodgkin lymphoma in Lebanon: a retrospective epidemiological study between 1984 and 2019
Variable | ≤ 64 years | ≥ 65 years | p | Statistical test used |
|---|---|---|---|---|
Gender | Â | Â | 0.737 | Chi-square |
 Male | 267 (55.1%) | 110 (53.7%) |  |  |
 Female | 218 (44.9%) | 95 (46.3%) |  |  |
Death | Â | Â | 0.847 | Chi-square |
 No | 363 (74.8%) | 152 (74.1%) |  |  |
 Yes | 122 (25.2%) | 53 (25.9%) |  |  |
Cell type NHL | Â | Â | 0.09 | Chi-square |
 B | 411 (89.2%) | 184 (93.4%) |  |  |
 T | 50 (10.8%) | 13 (6.6%) |  |  |
Lesion at diagnosis | Â | Â | 0.571 | Chi-square |
 Nodal | 303 (62.6%) | 133 (64.9%) |  |  |
 Extranodal | 181 (37.4%) | 72 (35.1%) |  |  |
Staging | Â | Â | 0.729 | Chi-square |
 1 | 69 (15.0%) | 28 (14.3%) |  |  |
 2 | 126 (27.4%) | 52 (26.5%) |  |  |
 3 | 110 (23.9%) | 55 (28.1%) |  |  |
 4 | 155 (33.7%) | 61 (31.1%) |  |  |
First line chemotherapy | Â | Â | 0.101 | Chi-square |
 RCHOP | 192 (50.5%) | 89 (56.7%) |  |  |
 Dose dense | 72 (18.9%) | 18 (11.5%) |  |  |
 Other regimens | 116 (30.5%) | 50 (31.8%) |  |  |
Radiotherapy | Â | Â | 0.01 | Chi-square |
 No | 380 (78.8%) | 178 (87.3%) |  |  |
 Yes | 102 (21.2%) | 26 (12.7%) |  |  |